Ver­sant and Ab­Cellera go deep­er on an­ti­bod­ies, push­ing for­ward a trio of stealth com­pa­nies

Ver­sant is putting the bow on a new deal with an­ti­body de­vel­op­er Ab­Cellera on Wednes­day.

The two com­pa­nies aren’t say­ing much, de­clin­ing to dis­close fi­nan­cial …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER